After a routine blood test led to his diagnosis, the 70-year-old travel expert urges everyone to prioritize health exams.
For the first time, Eupraxia is reporting 24-week data on symptom response from the highest dose cohort in the open label, Phase 1b/2a portion of the RESOLVE trial. The data is important because it is ...
A spike in polypropylene and polyethylene prices has hit the production of medical-grade polymers, a critical component in ...
The judge essentially said that RFK Jr. and his panel weren't even pretending to base their vaccine decisions on medical ...